Anatara Lifesciences Statistics

Total Valuation

ASX:ANR has a market cap or net worth of AUD 1.07 million. The enterprise value is -34,802.

Market Cap	1.07M
Enterprise Value	-34,802

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:ANR has 213.38 million shares outstanding. The number of shares has increased by 52.75% in one year.

Current Share Class	213.38M
Shares Outstanding	213.38M
Shares Change (YoY)	+52.75%
Shares Change (QoQ)	+12.51%
Owned by Insiders (%)	13.75%
Owned by Institutions (%)	13.33%
Float	125.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.26
PB Ratio	0.79
P/TBV Ratio	0.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.02
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.42

Current Ratio	4.42
Quick Ratio	4.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -147.32% and return on invested capital (ROIC) is -92.48%.

Return on Equity (ROE)	-147.32%
Return on Assets (ROA)	-76.07%
Return on Invested Capital (ROIC)	-92.48%
Return on Capital Employed (ROCE)	-142.58%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.16
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.50% in the last 52 weeks. The beta is 0.57, so ASX:ANR's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-87.50%
50-Day Moving Average	0.01
200-Day Moving Average	0.04
Relative Strength Index (RSI)	41.91
Average Volume (20 Days)	1,184,815

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ANR had revenue of AUD 250,513 and -1.93 million in losses. Loss per share was -0.01.

Revenue	250,513
Gross Profit	-1.07M
Operating Income	-1.94M
Pretax Income	-1.93M
Net Income	-1.93M
EBITDA	-1.94M
EBIT	-1.94M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 1.10 million in cash and n/a in debt, giving a net cash position of 1.10 million or 0.01 per share.

Cash & Cash Equivalents	1.10M
Total Debt	n/a
Net Cash	1.10M
Net Cash Per Share	0.01
Equity (Book Value)	1.36M
Book Value Per Share	0.01
Working Capital	1.36M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.86M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-775.12%
Pretax Margin	-771.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:ANR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.75%
Shareholder Yield	n/a
Earnings Yield	-181.19%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:ANR has an Altman Z-Score of -8.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.73
Piotroski F-Score	1